SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001085037-22-000065
Filing Date
2022-09-06
Accepted
2022-09-06 12:42:11
Documents
5
Period of Report
2022-08-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k082922.htm 6-K 7956
2 EXHIBIT 99.1 - FINANCIAL STATEMENTS ex99_1.htm EX-99.1 524041
3 EXHIBIT 99.2 - MD&A ex99_2.htm EX-99.2 298077
4 EXHIBIT 99.3 - CEO CERTIFICATION ex99_3.htm EX-99.3 7920
5 EXHIBIT 99.4 - CFO CERTIFICATION ex99_4.htm EX-99.4 7907
  Complete submission text file 0001085037-22-000065.txt   847234
Mailing Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1
Business Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1 604-248-8693
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-50112 | Film No.: 221227569
SIC: 2836 Biological Products, (No Diagnostic Substances)